NEW YORK (GenomeWeb) – Myriad Genetics today announced it has received approval from the US Food and Drug Administration for BRACAnalysis CDx as a companion diagnostic for AstraZeneca's Lynparza (olaparib), a new drug for advanced ovarian cancer associated with BRCA genes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.